Related Experiment Video
Updated: Jun 29, 2026

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
Olaparib-induced interstitial lung disease: A case series analysis
Mototaka Hattori1, Yu Mikami1, Midori Sato1
1Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Respiratory Investigation
|May 17, 2025
Summary
Olaparib-induced interstitial lung disease (OILD) presents with fever and lung opacities on CT scans. High lymphocytosis in bronchoalveolar lavage fluid may help diagnose OILD, which responds to prednisolone treatment.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Olaparib-induced interstitial lung disease (OILD) is a rare but severe adverse event.
- The imaging features and clinical progression of OILD require further clarification.
- Previous case reports necessitate additional characterization of OILD.

